Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,646 public trials 848 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Not Yet Recruiting

Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

NCT06845241

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Fujian Cancer Hospital Fuzhou, Fujian, China

Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

Henan Cancer Hosptital Zhengzhou, Henan, China

The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China

View Trial Details

Not Yet Recruiting

Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients

NCT06665737

Conditions: Agranulocytosis, Cytopenia, Febrile Neutropenia, +17 more
Locations: Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University Bangkok, Thailand

Rajavithi Hospital Bangkok, Thailand

Internal Medicine Unit, Pranongklao Hospital Nontaburi, Thailand

View Trial Details

Not Yet Recruiting

AZA Combined with R-GemOx for Elderly DLBCL Patients

NCT06778902

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +12 more
Locations: Daping Hospital, Third Military Medical University (Army Medical University) Chongqing, China

View Trial Details

Not Yet Recruiting

Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1

NCT06777264

Conditions: Acute Lymphoblastic Leukemia, B Cell ALL, Burkitt Lymphoma, +20 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

BV in the Treatment of Relapsed/refractory Hodgkin Lymphoma

NCT06761911

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Efficacy and Safety of Zuberitamab Combined with Bendamustine, Followed by Monotherapy Maintenance, in Treatment-naïve Follicular Lymphoma

NCT06757894

Conditions: Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Chidamide Plus Golidocitinib in Relapsed/Refractory Peripheral T-Cell Lymphoma

NCT06757387

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Dynamic CtDNA-guided Targeted Therapy in DLBCL

NCT06748521

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

The Value of Artificial Intelligence-based 18F-FDG PET/CT in Diferential Diagnosis, Efficacy Prediction and Prognosis Prediction of T-NK Cell Lymphoma: a Clinical Study

NCT06747299

Conditions: Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
Locations: Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

The Microbiome in Blood Cancer and HLH

NCT06734624

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Haemophagocytic Lymphohistiocytosis, +15 more
Locations: University of Nottingham Nottingham, Nottinghamshire, United Kingdom

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions